Skip to content Accessibility statement

Viruses turbo-charge bacterial evolution in cystic fibrosis infections

News

Posted on Tuesday 5 July 2016

Scientists at the University of York have found new evidence that tiny viruses called bacteriophages turbo-charge the evolution of bacteria that cause lung infections in Cystic Fibrosis patients.

The research team warn that antibiotics can activate bacteriophages, meaning certain medical therapies might make the infections even more difficult to treat.

Cystic Fibrosis (CF) patients suffer from life-long lung infections caused by the environmental bacterium Pseudomonas aeruginosa.

These infections worsen patient health and limit life-expectancy. Over the years of the infection, the bacteria evolve to become better adapted to the lung environment, becoming very difficult to treat.

The scientists found new evidence that viruses infecting the bacteria, called bacteriophages, can speed-up this bacterial evolution.

A team of scientists from the Universities of York, Liverpool and Salford evolved populations of the bacterium P. aeruginosa with or without bacteriophages in a growth medium designed to replicate the sputum in CF lungs. They then tracked evolutionary change in the bacterium using genome sequencing.

The study, published in the Proceedings of the National Academy of Sciences, reports that bacteria with bacteriophages evolved faster to adapt to life in sputum. This happened because the bacteriophage jumped into the bacterium’s DNA, increasing the number of useful mutations that natural selection could use.

Many of the mutations seen in the lab-evolved bacteria, including those caused by the bacteriophage, are also commonly seen in bacteria isolated from CF infections. Because bacteriophages live wherever you find bacteria, including in the lungs of CF patients, this could mean that they play an important role in bacterial evolution in the clinic.

Professor Michael Brockhurst, from the University of York’s Department of Biology, said: “To design better treatments and preserve our antibiotics we urgently need to better understand how bacteria evolve in infections.

“These new results suggest that bacteriophages may play a much bigger role than previously thought, by turbo-charging evolutionary adaptation.”

Further information

Research newsletter

Our monthly research newsletter features a curated mix of news, events, and recent discoveries delivered straight to your inbox.

Sign up

Explore more news

News

6 November 2026

The Minister for Science, Innovation and Investment, Chris McDonald MP, visited York’s historic Guildhall to learn how the University is driving economic growth and innovation across the region.

News

6 November 2026

The University of York has officially joined the UK Reproducibility Network (UKRN) as an institutional member, reinforcing its commitment to the highest standards of research rigour, transparency and inclusivity.

News

5 November 2026

The UK Government has lowered a key investment value, known as the headline social discount rate, from 3.5% to 3% following landmark research, giving greater weight to long-term environmental preservation, transport and hospital projects.

News

5 November 2026

A University of York student startup has been nominated for the global Earthshot Prize 2027 after developing a plant-based bio-polymer to replace traditional plastic.

News

5 November 2026

An AI assistant that conducts telephone consultations with patients is being trialled in the NHS to help clinicians monitor people with long-term illness.

Read more news